Tue, June 25, 2024
[ 12:00 AM ] - WOPRAI
Tue, June 18, 2024
[ 12:00 AM ] - WOPRAI
Thu, May 16, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 15, 2024
[ 12:00 AM ] - WOPRAI
Thu, April 11, 2024
Mon, February 12, 2024
[ 12:00 AM ] - WOPRAI
Tue, February 6, 2024
[ 12:00 AM ] - WOPRAI
Fri, September 22, 2023
[ 12:00 AM ] - WOPRAI
Tue, September 19, 2023
[ 12:00 AM ] - WOPRAI
Wed, September 13, 2023
[ 12:00 AM ] - WOPRAI
Wed, September 6, 2023
Tue, August 1, 2023
[ 12:00 AM ] - WOPRAI
Thu, July 6, 2023
Mon, June 26, 2023
[ 12:00 AM ] - WOPRAI
Tue, May 2, 2023
[ 12:00 AM ] - WOPRAI
Thu, April 20, 2023
[ 12:00 AM ] - WOPRAI
Tue, March 28, 2023
Wed, January 18, 2023
[ 12:00 AM ] - WOPRAI
Wed, November 2, 2022
Wed, September 14, 2022
[ 12:00 AM ] - WOPRAI
Fri, August 5, 2022
[ 12:00 AM ] - WOPRAI
Tue, May 24, 2022
[ 12:00 AM ] - WOPRAI
Mon, May 9, 2022
[ 12:00 AM ] - WOPRAI
Tue, May 3, 2022
[ 12:00 AM ] - WOPRAI
Tue, April 19, 2022
Fri, April 1, 2022
[ 12:00 AM ] - WOPRAI
Thu, March 24, 2022
[ 12:00 AM ] - WOPRAI
Wed, December 22, 2021
[ 12:00 AM ] - WOPRAI
Tue, November 23, 2021
Mon, July 26, 2021
Liisa Bayko Maintained (ALNY) at Buy with Increased Target to $260 on, Jun 25th, 2024
Liisa Bayko of Evercore ISI Group, Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy with Increased Target from $210 to $260 on, Jun 25th, 2024.
Liisa has made no other calls on ALNY in the last 4 months.
There are 5 other peers that have a rating on ALNY. Out of the 5 peers that are also analyzing ALNY, 0 agree with Liisa's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Liisa
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $275 on, Monday, June 24th, 2024
- Kostas Biliouris of "BMO Capital" Maintained at Buy and Held Target at $234 on, Monday, June 24th, 2024
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $400 on, Monday, June 24th, 2024
- Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy and Held Target at $283 on, Friday, June 21st, 2024
- Keay Nakae of "Chardan Capital" Maintained at Strong Buy and Held Target at $225 on, Friday, May 3rd, 2024
Contributing Sources